Dr. Bhuvnesh K Sharma, PhD is a Senior Director R&D (Translational Oncology) at ScyTeK Laboratories Inc., a premier Medical Biotech Co. Logan UT. He also holds appointment as Consultant, Celprogen Inc. Torrance, CA. He earned his MS and PhD degrees from India. He did his Post-Doctoral Trainings in Molecular Oncology/ Immuno-Virology at St. Mary’s Hospital Medical School, London, UK and Johns Hopkins University Medical Institutions, Baltimore, MD.
Dr. Sharma has previously served as Adjunct Associate Professor, Georgetown Univ. School of Medicine Washington DC; Senior Scientist, Weinberg Cancer Institute MedStar Health Franklin Square Medical Center, Baltimore, MD; Deputy Director of Institute of Prev. Oncology, N. Delhi, India; Visiting Scholar, Johns Hopkins University, Baltimore, MD; Visiting Scientist, Univ. of Maryland School of Medicine, Baltimore, MD. He is the recipient of Award & other distinguished recognitions for his discoveries on predictive cancer biomarkers. He has published numerous articles on cancer biomarkers and conducted research reviews on Emerging Cancer Vaccines and Intralesional tumor Immunotherapy. He is a noted expert in Melanoma Stem Cell research and Newer Optimism for Targeted Cancer Therapeutics. Dr. Sharma is also serving as an editorial board member of prestigious journals in Biomedicine/ Stem Cell Research/ Oncology.
Preclinical Cancer Research; Cancer Stem Cell Research; Genomic Tumor Pathology; Immunochemistry; Diagnostic Immunohistochemistry; Predictive Cancer Tissue Biomarkers; Tumor Immuno-Virology; Companion Cancer Diagnostics; Exploratory Adjuvant Tumor Immunotherapy